Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CTDSPL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNHG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEMIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMD4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF654 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VNN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGFOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC12A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF280B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBI3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM63B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XYLT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on